Merck & Co., Inc. — Director's Dealing 2022

Feb 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2022-02-24

Reporting Person: Li Dean Y (Executive VP & President, MRL)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-24	Common Stock	A	3023	$73.51	Acquired	15462.118	Direct

Footnotes

F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/19. Performance shares were paid out at 140 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2021.

F2: Holdings include shares acquired in dividend reinvestment transactions.